1. Home
  2. MNMD vs HFWA Comparison

MNMD vs HFWA Comparison

Compare MNMD & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • HFWA
  • Stock Information
  • Founded
  • MNMD 2019
  • HFWA 1927
  • Country
  • MNMD United States
  • HFWA United States
  • Employees
  • MNMD N/A
  • HFWA N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • HFWA Banks
  • Sector
  • MNMD Health Care
  • HFWA Finance
  • Exchange
  • MNMD Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • MNMD 811.9M
  • HFWA 815.9M
  • IPO Year
  • MNMD N/A
  • HFWA N/A
  • Fundamental
  • Price
  • MNMD $12.51
  • HFWA $23.55
  • Analyst Decision
  • MNMD Strong Buy
  • HFWA Buy
  • Analyst Count
  • MNMD 6
  • HFWA 4
  • Target Price
  • MNMD $26.50
  • HFWA $28.50
  • AVG Volume (30 Days)
  • MNMD 1.8M
  • HFWA 179.6K
  • Earning Date
  • MNMD 11-06-2025
  • HFWA 10-23-2025
  • Dividend Yield
  • MNMD N/A
  • HFWA 4.00%
  • EPS Growth
  • MNMD N/A
  • HFWA 13.61
  • EPS
  • MNMD N/A
  • HFWA 1.43
  • Revenue
  • MNMD N/A
  • HFWA $221,312,000.00
  • Revenue This Year
  • MNMD N/A
  • HFWA $22.09
  • Revenue Next Year
  • MNMD N/A
  • HFWA $9.26
  • P/E Ratio
  • MNMD N/A
  • HFWA $16.80
  • Revenue Growth
  • MNMD N/A
  • HFWA 3.23
  • 52 Week Low
  • MNMD $4.70
  • HFWA $19.84
  • 52 Week High
  • MNMD $12.94
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 66.16
  • HFWA 38.46
  • Support Level
  • MNMD $11.81
  • HFWA $23.68
  • Resistance Level
  • MNMD $12.94
  • HFWA $24.82
  • Average True Range (ATR)
  • MNMD 0.86
  • HFWA 0.45
  • MACD
  • MNMD 0.17
  • HFWA -0.12
  • Stochastic Oscillator
  • MNMD 88.48
  • HFWA 0.00

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: